Galmed Pharmaceuticals Ltd
NASDAQ:GLMD
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Galmed Pharmaceuticals Ltd
NASDAQ:GLMD
|
IL |
|
V
|
Value Grupo Financiero SAB de CV
BMV:VALUEGFO
|
MX |
|
P
|
Paringa Resources Ltd
ASX:PNL
|
US |
|
M
|
Mako Mining Corp
OTC:MAKOF
|
CA |
|
A
|
Arcellx Inc
NASDAQ:ACLX
|
US |
|
Green Cures & Botanical Distribution Inc
OTC:GRCU
|
US |
|
R
|
RaonSecure Co Ltd
KOSDAQ:042510
|
KR |
|
Zhejiang Gongdong Medical Technology Co Ltd
SSE:605369
|
CN |
|
Halberd Corp
OTC:HALB
|
US |
|
District Metals Corp
OTC:DMXCF
|
CA |
|
P
|
Phu Tai JSC
VN:PTB
|
VN |
|
C
|
Chi Kan Holdings Ltd
HKEX:9913
|
HK |
|
Plastic2Oil Inc
OTC:PTOI
|
US |
|
Naturhouse Health SA
F:2NH
|
ES |
|
KP Tissue Inc
TSX:KPT
|
CA |
|
A
|
Autohellas SA
ATHEX:OTOEL
|
GR |
|
BLIS Technologies Ltd
NZX:BLT
|
NZ |
|
A
|
Australian Rare Earths Ltd
ASX:AR3
|
AU |
|
BW Offshore Ltd
OSE:BWO
|
BM |
|
Scandi Standard AB (publ)
STO:SCST
|
SE |
|
Paccar Inc
NASDAQ:PCAR
|
US |
|
Greater Cannabis Company Inc
OTC:GCAN
|
US |
|
VEON Ltd
NASDAQ:VEON
|
NL |
Bankruptcy Probability
Galmed Pharmaceuticals Ltd's probability of bankruptcy is hidden . The solvency score is hidden .
We take all the information about a company's solvency (such as how easily a company can pay interest on its outstanding debt, how much cash it has, the amount of debt, and more) and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Galmed Pharmaceuticals Ltd Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| IL |
|
Galmed Pharmaceuticals Ltd
NASDAQ:GLMD
|
2.9m USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
365.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
184.6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
173.9B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
110.3B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
80.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| AU |
|
CSL Ltd
ASX:CSL
|
67B AUD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
39.6B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Galmed Pharmaceuticals Ltd's probability of bankruptcy is hidden .
The probability of bankruptcy is estimated using credit risk models that assess its financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Galmed Pharmaceuticals Ltd has no debt.
You can find a full breakdown on its Balance Sheet.
